Alpine Immune Sciences, Inc. (ALPN) Financials

ALPN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 240.5 million 78.9 million
2023-06-30 252.8 million 83.4 million
2023-03-31 262.1 million 92.6 million
2022-12-31 286.7 million 107.3 million

ALPN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -15.8 million 2.7 million
2023-06-30 -18.4 million 2.6 million
2023-03-31 -26.2 million 2.6 million
2022-12-31 -16.9 million 2.5 million

ALPN Net Income

No data available :(

ALPN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 193.5 million - 10.2 million
2023-06-30 203.8 million - 10.4 million
2023-03-31 194.9 million - 10.6 million
2022-12-31 237.6 million - 10.8 million

ALPN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 49.2 million
2023-06-30 48.0 million
2023-03-31 47.6 million
2022-12-31 45.9 million

ALPN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1000 19.2 million 5.4 million -
2023-06-30 279000 19.2 million 5.0 million -
2023-03-31 93000 19.6 million 5.4 million -
2022-12-31 116000 18.8 million 4.4 million -

ALPN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 10.0 million 146000
2023-06-30 8.6 million 142000
2023-03-31 9.4 million 140000
2022-12-31 2.8 million 145000

ALPN

Price: $64.56

52 week price:
6.71
64.62

Earnings Per Share: -0.64 USD

P/E Ratio: -22.30

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 35394

Ebitda: 2.3 million

Market Capitalization: 2.6 billion

Links: